Heart-Type Fatty Acid Binding Protein: A Better Cardiac Biomarker than CK-MB and Myoglobin in the Early Diagnosis of Acute Myocardial Infarction
- PMID: 26557510
- PMCID: PMC4625229
- DOI: 10.7860/JCDR/2015/15132.6684
Heart-Type Fatty Acid Binding Protein: A Better Cardiac Biomarker than CK-MB and Myoglobin in the Early Diagnosis of Acute Myocardial Infarction
Abstract
Background: Early diagnosis and therapeutic intervention can improve the outcome of acute myocardial infarction (AMI). However, there are no satisfactory cardiac biomarkers for the diagnosis of AMI within 6 hours of onset of symptoms. Among novel biochemical markers of AMI, heart-type fatty acid binding protein (H-FABP) is of particular interest.
Aim: To compare the diagnostic value of H-FABP with that of CK-MB and myoglobin in suspected AMI patients within first 6 hours after the onset of symptoms.
Settings and design: The study includes 40 AMI cases and 40 non-cardiac chest pain otherwise healthy controls. The cases and controls were further divided into 2 groups depending on the time since chest pain as those subjects within 3 hours and those between 3-6 hours of onset of chest pain.
Materials and methods: In all the cases and controls, serum H-FABP, CK-MB and myoglobin concentrations were measured by Immunoturbidimetric method, immuno-inhibition method and Chemiluminescence immunoassay respectively.
Statistical analysis: Data is presented as mean ± SD values. Differences between means of two groups were assessed by Student t-test. Sensitivity, Specificity, Positive predictive value, Negative predictive values were calculated and ROC curve analysis was done to assess the diagnostic validity of each study parameter.
Results: The sensitivity, specificity, PPV, NPV of H-FABP were greater than CK-MB and myoglobin and ROC curve analysis demonstrated highest area under curve for H-FABP followed by myoglobin and CK-MB in patients with suspected AMI both within 3 hours and 3-6 hours after the onset of chest pain.
Conclusion: The diagnostic efficiency of H-FABP is greater than CK-MB and myoglobin for the early diagnosis of AMI within first 6 hours of chest pain. H-FABP can be used as an additional diagnostic tool for the early diagnosis of AMI.
Keywords: Chest pain; Diagnostic validity; Immunoturbidimetric method; ROC analysis; Sensitivity.
Figures
Similar articles
-
Human heart-type cytoplasmic fatty acid-binding protein (H-FABP) for the diagnosis of acute myocardial infarction. Clinical evaluation of H-FABP in comparison with myoglobin and creatine kinase isoenzyme MB.Clin Chem Lab Med. 2000 Mar;38(3):231-8. doi: 10.1515/CCLM.2000.034. Clin Chem Lab Med. 2000. PMID: 10905760
-
Heart-Type Fatty Acid-Binding Protein, in Early Detection of Acute Myocardial Infarction: Comparison with CK-MB, Troponin I and Myoglobin.Indian J Clin Biochem. 2016 Oct;31(4):439-45. doi: 10.1007/s12291-015-0544-7. Epub 2016 Jan 13. Indian J Clin Biochem. 2016. PMID: 27605741 Free PMC article.
-
Role of heart-type fatty acid binding protein in early detection of acute myocardial infarction in comparison with cTnI, CK-MB and myoglobin.J Huazhong Univ Sci Technolog Med Sci. 2004;24(5):449-51, 459. doi: 10.1007/BF02831105. J Huazhong Univ Sci Technolog Med Sci. 2004. PMID: 15641689
-
Serum markers in the emergency department diagnosis of acute myocardial infarction.Emerg Med Clin North Am. 2001 May;19(2):321-37. doi: 10.1016/s0733-8627(05)70186-3. Emerg Med Clin North Am. 2001. PMID: 11373981 Review.
-
Laboratory diagnosis of patients with acute chest pain.Clin Chem Lab Med. 2000 Mar;38(3):187-97. doi: 10.1515/CCLM.2000.027. Clin Chem Lab Med. 2000. PMID: 10905753 Review.
Cited by
-
Glycogen Phosphorylase BB: A more Sensitive and Specific Marker than Other Cardiac Markers for Early Diagnosis of Acute Myocardial Infarction.Indian J Clin Biochem. 2018 Jul;33(3):356-360. doi: 10.1007/s12291-017-0685-y. Epub 2017 Aug 3. Indian J Clin Biochem. 2018. PMID: 30072837 Free PMC article.
-
Prognostic utility of heart-type fatty acid-binding protein in patients with stable coronary artery disease and impaired glucose metabolism: a cohort study.Cardiovasc Diabetol. 2020 Feb 10;19(1):15. doi: 10.1186/s12933-020-0992-0. Cardiovasc Diabetol. 2020. PMID: 32041617 Free PMC article.
-
Systolic Pulmonary Artery Pressure and Cardiovascular Biomarkers-New Non-Invasive Ways to Detect Pulmonary Hypertension in Patients with Severe Aortic Valve Stenosis Undergoing TAVR?Rev Cardiovasc Med. 2022 Jun 24;23(7):224. doi: 10.31083/j.rcm2307224. eCollection 2022 Jul. Rev Cardiovasc Med. 2022. PMID: 39076911 Free PMC article.
-
Evaluation of Dual Marker Approach Using Heart-Type Fatty Acid Binding Protein and High Sensitivity Troponin-I as an Alternative to Serial Sampling for Diagnosis of Acute Myocardial Infarction.EJIFCC. 2022 Apr 11;33(1):43-55. eCollection 2022 Apr. EJIFCC. 2022. PMID: 35645696 Free PMC article.
-
Activation of PTEN/P13K/AKT Signaling Pathway by miRNA-124-3p-Loaded Nanoparticles to Regulate Oxidative Stress Attenuates Cardiomyocyte Regulation and Myocardial Injury.Oxid Med Cell Longev. 2022 Oct 11;2022:8428596. doi: 10.1155/2022/8428596. eCollection 2022. Oxid Med Cell Longev. 2022. Retraction in: Oxid Med Cell Longev. 2023 Dec 29;2023:9768785. doi: 10.1155/2023/9768785 PMID: 36267811 Free PMC article. Retracted.
References
-
- Alhashemi JA. Diagnostic accuracy of a bedside qualitative immunochromatographic test for acute myocardial infarction. Am J Emerg Med. 2006;24:149–55. - PubMed
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous